Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

920 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study.
Spagnuolo M, Costantini M, Ferriero M, Varmi M, Sperduti I, Regazzo G, Cicchillitti L, Díaz Méndez AB, Cigliana G, Pompeo V, Russo A, Laquintana V, Mastroianni R, Piaggio G, Anceschi U, Brassetti A, Bove A, Tuderti G, Flammia RS, Gallucci M, Simone G, Rizzo MG. Spagnuolo M, et al. Among authors: costantini m. J Exp Clin Cancer Res. 2020 Apr 17;39(1):68. doi: 10.1186/s13046-020-01550-w. J Exp Clin Cancer Res. 2020. PMID: 32303246 Free PMC article.
Zero-ischemia minimally invasive partial nephrectomy.
Simone G, Ferriero M, Papalia R, Costantini M, Guaglianone S, Gallucci M. Simone G, et al. Among authors: costantini m. Curr Urol Rep. 2013 Oct;14(5):465-70. doi: 10.1007/s11934-013-0359-0. Curr Urol Rep. 2013. PMID: 23893291 Review.
PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience.
Merola R, Tomao L, Antenucci A, Sperduti I, Sentinelli S, Masi S, Mandoj C, Orlandi G, Papalia R, Guaglianone S, Costantini M, Cusumano G, Cigliana G, Ascenzi P, Gallucci M, Conti L. Merola R, et al. Among authors: costantini m. J Exp Clin Cancer Res. 2015 Feb 6;34(1):15. doi: 10.1186/s13046-015-0127-8. J Exp Clin Cancer Res. 2015. PMID: 25651917 Free PMC article.
AMBRA1 and SQSTM1 expression pattern in prostate cancer.
Falasca L, Torino F, Marconi M, Costantini M, Pompeo V, Sentinelli S, De Salvo L, Patrizio M, Padula C, Gallucci M, Piacentini M, Malorni W. Falasca L, et al. Among authors: costantini m. Apoptosis. 2015 Dec;20(12):1577-86. doi: 10.1007/s10495-015-1176-3. Apoptosis. 2015. PMID: 26423274 Free PMC article.
Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G, Tuderti G, Anceschi U, Papalia R, Ferriero M, Misuraca L, Minisola F, Mastroianni R, Costantini M, Guaglianone S, Sentinelli S, Gallucci M. Simone G, et al. Among authors: costantini m. World J Urol. 2017 May;35(5):789-794. doi: 10.1007/s00345-016-1923-2. Epub 2016 Aug 30. World J Urol. 2017. PMID: 27578234
Papillary type 2 versus clear cell renal cell carcinoma: Survival outcomes.
Simone G, Tuderti G, Ferriero M, Papalia R, Misuraca L, Minisola F, Costantini M, Mastroianni R, Sentinelli S, Guaglianone S, Gallucci M. Simone G, et al. Among authors: costantini m. Eur J Surg Oncol. 2016 Nov;42(11):1744-1750. doi: 10.1016/j.ejso.2016.08.003. Epub 2016 Aug 22. Eur J Surg Oncol. 2016. PMID: 27593224
Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.
Fabrizio FP, Costantini M, Copetti M, la Torre A, Sparaneo A, Fontana A, Poeta L, Gallucci M, Sentinelli S, Graziano P, Parente P, Pompeo V, De Salvo L, Simone G, Papalia R, Picardo F, Balsamo T, Flammia GP, Trombetta D, Pantalone A, Kok K, Paranita F, Muscarella LA, Fazio VM. Fabrizio FP, et al. Among authors: costantini m. Oncotarget. 2017 Feb 14;8(7):11187-11198. doi: 10.18632/oncotarget.14492. Oncotarget. 2017. PMID: 28061437 Free PMC article.
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition.
Cannistraci A, Federici G, Addario A, Di Pace AL, Grassi L, Muto G, Collura D, Signore M, De Salvo L, Sentinelli S, Simone G, Costantini M, Nanni S, Farsetti A, Coppola V, De Maria R, Bonci D. Cannistraci A, et al. Among authors: costantini m. Oncogene. 2017 Jun 29;36(26):3718-3728. doi: 10.1038/onc.2016.505. Epub 2017 Feb 13. Oncogene. 2017. PMID: 28192399
920 results